Manufacturer

Shandong Xinhua Medical Instrument Co., Ltd.

Address: No.7 Taimei Road, High-tech Zone, Zhangdian District, Zibo City, Shandong Province

Company website: http://www.shinva.net

Company Overview

Shandong Xinhua Medical Instrument Co., Ltd. was established in 1943 and is one of the earliest medical instrument manufacturers in China. In September 2002, it was listed on the Shanghai Stock Exchange (600587). It is a domestic advanced health industry group integrating medical instrument and pharmaceutical equipment research, production, sales, medical services, trade and logistics. It is the chairman unit of the China Medical Device Industry Association, the chairman unit of the National Infection and Control Technology Professional Committee, the chairman unit of the China Radiotherapy Industry Technology Innovation Strategic Alliance, the director unit of the China Pharmaceutical Equipment Industry Association, and the director unit of the China Medical Equipment Engineering Association.In the medical equipment sector, nine advanced product lines with sophisticated configurations and complete technologies have been formed, covering infection control, radiotherapy and imaging, surgical instruments and orthopedics, operating room engineering and equipment, oral equipment and consumables, in vitro diagnostic reagents and instruments, biological materials and consumables, dialysis equipment and consumables, medical environmental protection and other fields. At present, the variety and output of infection control equipment are among the best in the world; the research and development and production of radiotherapy equipment are large-scale and full-variety in China, with a high domestic market share and advanced technology level; in the pharmaceutical equipment sector, it is composed of four major engineering and technology centers for biopharmaceuticals, special infusions, traditional Chinese medicine preparations, and solid preparations, integrating pharmaceutical equipment research and development, manufacturing and sales. In addition to the production of conventional pharmaceutical equipment, it provides high-quality services in the trinity of "pharmaceutical technology, pharmaceutical equipment, and pharmaceutical engineering"; at the same time, it provides a whole package service for the construction of chemical, biological, and herbal medicine factories to solve all worries for customers.In the field of medical services, Xinhua Medical continues to enhance its brand competitiveness and reputation. Relying on professional investment, construction, operation, procurement and service platforms, it aims to build a modern hospital group with advanced medical concepts, cutting-edge scientific research, brand operation chains and organic integration of resources.In the future, Xinhua Medical will provide more patients with perfect medical services with a new look of collectivization, specialization and standardization, and realize the grand dream of developing the health industry. In the medical trade sector, Xinhua Medical actively responds to new market patterns and changes, maintains the company's continuous competitiveness and healthy development vitality, and conducts business model exploration and innovation, aiming to create a new marketing pattern integrating domestic marketing, international trade, e-commerce, and trade logistics, fully unleash the marketing potential, and transform to new models and new formats. Care about health and be honest to the world. Standing at a new historical starting point and facing new development opportunities, Xinhua Medical will, as always, keep pace with the times, bravely face difficulties and challenges with confidence, innovation and hard work, and continue to work hard for the cause of human health, to build a monument for China's medical device industry, and to create a world-renowned medical device manufacturer!

Zhejiang Canaan Technology Co., Ltd.

Address: Dongou Industrial Park, Oubei Town, Yongjia County, Wenzhou City, Zhejiang Province

Company website: http://www.china-jianan.com

Company Overview

Zhejiang Canaan Technology Co., Ltd. (stock code: 300412) was established in 2000 and is headquartered in Yongjia Industrial Park, Wenzhou City. It is a well-known listed company in China's pharmaceutical equipment industry. Existing members include Nanjing Canaan Bison Technology Co., Ltd., Beijing Canaan Lemite Technology Co., Ltd., Zhejiang Canaan Kaixinlong Technology Co., Ltd., Zhejiang Canaan Xiaojiang Technology Co., Ltd., Shanghai Kaixian Fluid Technology Co., Ltd., Nanjing Bisonmite Intelligent Technology Co., Ltd., and Yunnan Canaan Feiqi Technology Co., Ltd.Canaan Technology is positioned as a customer expert with leading products. It is a domestic pharmaceutical equipment company that can provide three complete granulation process solutions (wet granulation, dry granulation, boiling granulation). After Canaan Technology went public, it quickly laid out the fluid equipment and powder equipment industries around the big health industry according to the "one body and two wings" strategy, and completed the development from single equipment to overall comprehensive solutions. At present, it can provide customers with solid preparation line solutions, API line solutions, pharmaceutical water systems, intelligent warehousing and logistics systems, drug research and development/traditional Chinese medicine testing comprehensive services, EPC engineering general contracting and other services, which are widely used in pharmaceuticals, food, health products, fine chemicals, new energy, new materials and other industries.Canaan Technology actively "responds to Made in China 2025 and promotes Pharmaceutical Industry 4.0" and has established the "Canaan Intelligent Manufacturing Research Institute" to be responsible for the development of intelligent technology for solid preparations. It has cooperated with Tongji University to establish a "solid preparation intelligent model line" in the Nanjing factory and developed an AGV car that meets GMP requirements, which can provide pharmaceutical companies with intelligent solutions for solid preparations. In addition, Canaan Company is also actively promoting the intelligence of equipment production and manufacturing processes, and promoting the "C-M Digital Factory" in the Wenzhou base. It is a pharmaceutical equipment company that uses stereoscopic warehouses and intelligent logistics within the company. Canaan Technology is committed to improving the level of pharmaceutical technology and promoting industrial upgrading. It is a pharmaceutical equipment company that has established a "Pharmaceutical Research Institute". It has established a small-scale test laboratory platform and a testing laboratory in the Jiangsu Life Science and Technology Innovation Park in Nanjing, which can provide pharmaceutical companies with innovative drug technology cooperation, generic drug consistency evaluation outsourcing services, solid preparations sustained-release preparations technology cooperation, preparation process development and support, and traditional Chinese medicine testing services.Canaan Technology's products are exported to the United States, Germany, Canada, Italy, Japan, South Korea and other countries and regions, and are well recognized by domestic and foreign users. It has established cooperative relations with well-known domestic and foreign pharmaceutical companies such as Pfizer, Bayer, Johnson & Johnson, GlaxoSmithKline, Sanofi, Harbin Pharmaceutical Group, China National Pharmaceutical Group, Shijiazhuang Pharmaceutical Group, Shanghai Pharmaceutical Group, Yunnan Baiyao, Hengrui Medicine, Fosun Pharma, Tasly, China Resources Sanjiu, Renfu Pharmaceutical, and Yiling Pharmaceutical.Canaan Technology continues to "focus on health value" and advocates a corporate culture of "love". It takes it as its mission to improve the level of pharmaceutical technology and promote industrial upgrading, striving to become a century-old national brand in the pharmaceutical machinery industry and a world-class pharmaceutical equipment industry group.

China Resources Pharmaceutical Holdings Limited

Address: Building 7, No.2, North Third Ring Road, Chaoyang District, Beijing

Company website: https://www.crpharm.com/

Company Overview

China Resources Double Crane Pharmaceutical Co., Ltd. has a glorious history of more than 80 years. It was founded in 1939. It was originally a military pharmaceutical factory born in the Taihang Mountain Revolutionary Base and was named Lihua Pharmaceutical Factory. In 1949, it moved to Beijing with the army and was later renamed Beijing Pharmaceutical Factory. It developed into a large-scale state-owned chemical pharmaceutical comprehensive preparation enterprise, laying the foundation for Beijing's modern chemical pharmaceutical industry. It was listed on the Shanghai Stock Exchange in 1997 and was renamed Beijing Double Crane Pharmaceutical Co., Ltd. Through external expansion, it has become a cross-regional group based in Beijing and radiating across the country. In 2010, it joined the Fortune Global 500 company China Resources Group and was renamed China Resources Double Crane in 2012. It is now one of the business units in the field of health of China Resources Group.The company's main business covers new drug research and development, preparation production, drug sales, API production and pharmaceutical equipment. It has rich product lines and brand advantages, high-quality product quality and cost control, strong channel and terminal coverage and management capabilities, international advantages, dynamic team advantages and profound cultural heritage. Its economic strength, competitive vitality and sustainable development capabilities are among the top domestic pharmaceutical companies. In 2022, it achieved operating income of 9.447 billion yuan and net profit of 1.215 billion yuan. The company actively laid out four business platforms, namely generic drug business, infusion business, differentiated drug business and innovative drug business, and deeply cultivated the fields of chronic diseases, infusion, pediatrics, nephrology, psychiatry/neurology, and entered the field of tumors. The annual sales of 18 key products, including No. 0, Fusuiyue, nifedipine sustained-release tablets, pitavastatin calcium tablets, Tangshiping, BFS infusion, Kelisu, peritoneal dialysis fluid, and magnesium valproate sustained-release tablets, exceeded 100 million yuan. It owns trademarks such as "Shuanghe Jitu", "Sai Ke", and "Xiangzhong", and has won many honors.The company has accelerated its innovative transformation, built multiple technology platforms, continuously enriched its product clusters, continued to increase its R&D investment, and actively cooperated with domestic and foreign universities, R&D institutions and pharmaceutical companies to accelerate product acquisition. It has first-class domestic production and manufacturing capabilities, with 20 production bases located in 14 provinces and cities in North China, Northwest China, Central China, South China and other regions. It has built an advanced production management system, and its quality management is benchmarked against international first-class standards. The sales network covers 33 provinces, municipalities, autonomous regions and special administrative regions across the country, and has a strong influence in the markets of North China, Jiangsu and Zhejiang, and the infusion bases. Some of its APIs and preparations are exported to more than 40 countries in the international market. Through rich product support, thoughtful and considerate marketing services, good terminal control capabilities and a professional marketing team, we work together with our customers to achieve a win-win situation.In the future, CR Double Crane will continue to accelerate innovation transformation and quality development, implement the "1246" model of CR Group, serve the people's livelihood and build major equipment for the country, and strive to become a world-class pharmaceutical company trusted by the public and driven by innovation, and make greater contributions to industry development and public health.

Jiangsu Saideli Pharmaceutical Machinery Manufacturing Co., Ltd.

Address: No.31, Zhongzhou Road, Jingjiang City, Taizhou City, Jiangsu Province

Company website: http://www.saideli.com

Company Overview

Jiangsu Saideli Pharmaceutical Machinery Manufacturing Co., Ltd. is a high-tech enterprise integrating scientific research and production. The company was established in 1953. The head office of Saideli is divided into Jiangsu Saideli Pharmaceutical Machinery Manufacturing Co., Ltd., Denmark FERREO Company, Jiangsu Zhongyi Environmental Protection Technology Co., Ltd., Jiangsu Zhongyi Energy Saving Technology Co., Ltd., Jiangsu Saideli Management Consulting Service Co., Ltd., Jiangsu Keli Internet Information Technology Co., Ltd., Jiangsu Deshuang New Energy Equipment Co., Ltd., Jiangsu Saideli Intelligent Technology Co., Ltd., Jiangsu Saideli Diagnostic Technology Co., Ltd., Jingjiang City Fine Filtration Equipment Co., Ltd., and Jingjiang City Saideli Agricultural Ecology Co., Ltd., covering a total area of more than 500,000 square meters.The company is located in Jingjiang City, Jiangsu Province. It develops high-tech products that meet the GMP standards for pharmaceutical production and replace imports, leading the development of the domestic industry. It has developed more than 100 varieties of products in China, including FW horizontal bag centrifuge, vertical filter press, hanging bag centrifuge, fully automatic spiral unloading centrifuge, GKC sterile horizontal scraper centrifuge, siphon scraper centrifuge, computer program-controlled large-caliber vertical scraper centrifuge, fully automatic bag-pulling centrifuge, centrifugal dryer in high-standard clean area, continuously operated pressurized drum filter, disc, disc screw centrifuge, etc. The sales network is all over the world, exported to Germany, Spain, Brazil, Argentina, Russia, Latvia, Indonesia, Vietnam, Thailand, Malaysia, South Korea, India, Japan, Ukraine and other parts of the world, and is well received by domestic and foreign users.Saideli has always implemented the development policy of developing enterprises through science and technology. It not only has a strong technology research and development center, but also cooperates with world-class enterprises, domestic universities and scientific research institutes. The research and development center currently has 5 doctoral supervisors, 8 professor-level senior engineers, 6 foreign experts, 18 senior engineers, 65 engineers, 78 assistant-level engineering and technical personnel, a domestic professional research institute and a separation and drying technology laboratory, as well as 98 sets of various scientific research equipment. At present, it has obtained more than 100 invention patents and utility model patents.In 2019, Jiangsu Saideli invested in building a new global centrifuge diagnostic center. After the completion of the project, it will realize real-time online monitoring, remote operation and maintenance services, and remote fault diagnosis of centrifuges. As a modern enterprise with a high starting point in the field of mechanical manufacturing, Saideli has always adhered to the corporate spirit of "pragmatism, innovation, and transcendence", established a clear quality concept, focused on core advantages, and has 520 sets of various general (special) manufacturing equipment. At the same time, it has imported many world-leading processing equipment and built a positive pressure workshop that meets GMP requirements in 2012.The company firmly establishes national aspirations, faces the future, and bravely creates great achievements. It further implements the four major strategies of "fine extension, large-caliber leadership, outward breakthrough, and independent innovation" to help Chinese and foreign customers create more glories and add glory to Chinese companies' dominance in the world.

Aoxing Life Science Co., Ltd.

Address: Room 1217-1218, Building B, Gemdale Plaza, No.91 Jianguo Road, Chaoyang District, Beijing

Company website: http://www.austar.com.hk

Company Overview

Hong Kong Aoxing Group is a technology-based pharmaceutical engineering solution provider with business scope in more than 50 countries and regions around the world. The group cooperates with internationally renowned pharmaceutical companies and is committed to protecting and improving human health. More than 2,000 employees provide customers with technically guaranteed pharmaceutical engineering solutions in different regions, helping customers build drug production facilities and contributing to global drug safety and effectiveness. The Group has comprehensive technical knowledge of the pharmaceutical industry, and has advanced technical application capabilities and high-quality equipment and systems in the fields of clean utilities, pharmaceutical automation and information technology, pharmaceutical formulation process technology, bioprocessing and technology, compliance & operational excellence, laboratory technology and facilities, biosafety technology and facilities, cleaning, sterilization, disinfection, clean room/HVAC/EMS/BMS, quality/measurement and analysis, filling, freeze-drying and testing, and closed technology.Global technical experts, professional equipment production bases, and experienced engineering execution teams ensure the Group's capabilities in technology research and development, high-quality pharmaceutical equipment manufacturing, engineering project management, and execution; the dedicated service team provides customers with continuous support in terms of operations and cost-effectiveness to help customers achieve long-term benefits. Through partners, the Group also distributes various types of quality-assured pharmaceutical equipment and life science consumables.AUSTAR Group was founded in 1991 and is headquartered in Beijing, China. On November 7, 2014, the Group was successfully listed on the Hong Kong Stock Exchange (stock code: 6118). The Group has a number of business and product brands that occupy an important position in the domestic and international markets, including H+E Pharma, BIOSYSTEC, STERIS-AUSTAR, ROTA-AUSTAR, Pharma LeanTec, Pharma LeanDigital, AUSMILL, Aunity, Purvita, etc.

Zhejiang Yaguang Technology Co., Ltd.

Address: No.4525, Binhai 3rd Road, Binhai Park, Wenzhou Economic and Technological Development Zone, Zhejiang Province

Company website: http://www.china-yaguang.com/

Company Overview

Zhejiang Yaguang Technology Co., Ltd. was founded in 1996. The company is headquartered in Wenzhou, Zhejiang. It is committed to the research and development and production of professional equipment in the fields of pharmaceuticals, fine chemicals, environmental protection, new energy, etc. After more than 20 years of development and accumulation, Zhejiang Yaguang Technology Co., Ltd. has now developed into a listed company with two wholly-owned companies and one holding subsidiary. The company has successively developed and manufactured core equipment such as rubber stopper cleaning machines, filter washing and drying machines and API production lines, MVR steam compressors and integrated systems, and high-salt wastewater treatment equipment and systems, establishing a dominant position in the industry product segment market.The company's main products include: cleaning products (rubber stopper cleaning machine, aluminum cap cleaning machine and transfer system), API raw material production line (reaction crystallization tank, filter washing and drying machine, grinding machine, single cone mixing and drying machine, filling and powder transmission system), MVR steam compressor and integrated system, COD high-salt wastewater treatment device, ultra-gravity distillation bed system. Among them, the rubber stopper cleaning machine and filter washing and drying machine are the drafting units of national industry standards, with more than 200 patented technologies. The products have passed the US FDA, EU CGMP and Japan GMP verification in many domestic and foreign pharmaceutical companies. The company has a provincial R&D center with first and second level pressure vessel and ASME design qualifications.Relying on a solid technical foundation, advanced management concepts and excellent corporate culture, Yaguang has been moving forward steadily, striving to build the company into a first-class global professional pharmaceutical process solution service provider.